News
The regulator found the undeclared medication used for treating erectile dysfunction in laboratory tests of the product.
The TGA has issued a warning around taking certain tablets after testing found undeclared prescription medication. (Photo: TGA)
The Therapeutic Goods Administration (TGA) has issued a safety warning after conducting tests that found sildenafil in a collagen supplement.
It says taking the tablets contained in the product, called Natures Valley Collagen Builder, ‘may pose a serious risk’ to health and should not be taken.
In its tests, the TGA found 199.3mg of sildenafil per tablet – more than the recommended daily dose of the drug, which is a Schedule 4 prescription-only medication used for the treatment of erectile dysfunction.
Originally sold exclusively as Viagra, the drug is now off-patent and also produced as a generic by other manufacturers.
The TGA warns the medication has potentially dangerous interactions with nitrates prescription drugs that could lower blood pressure to dangerous levels, and advises anyone concerned after using the product to consult their healthcare practitioner.
The regulator also said the supply of the tablets with undeclared sildenafil is illegal and that it is working with the Australian Border Force to help stop future shipments of the product from entering the country.
‘I urge consumers to exercise extreme caution when buying medicines and medical devices online including through social media and other digital platforms,’ said the TGA’s chief medical advisor, Professor Robyn Langham.
‘Australians currently using products, particularly prescription medicines obtained from overseas or online, should refer to the multiple safety alerts and advisories issued by the TGA and speak with their health professional about the right option for their circumstance to ensure their safety.’
Log in below to join the conversation.
collagen supplement safety warning TGA Therapeutic Goods Administration
newsGP weekly poll
What should the RACGP prioritise to improve the experience of GPs in training?
